These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 20417810)

  • 1. Calcineurin inhibitor-related cholestasis complicating lung transplantation.
    Oto T; Okazaki M; Takata K; Egi M; Yamane M; Toyooka S; Sano Y; Snell GI; Goto K; Miyoshi S
    Ann Thorac Surg; 2010 May; 89(5):1664-5. PubMed ID: 20417810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conversion to sirolimus for chronic allograft nephropathy and calcineurin inhibitor toxicity and the adverse effects of sirolimus after conversion.
    Sayin B; Karakayali H; Colak T; Sevmis S; Pehlivan S; Demirhan B; Haberal M
    Transplant Proc; 2009 Sep; 41(7):2789-93. PubMed ID: 19765436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conversion from calcineurin inhibitor to sirolimus in pediatric chronic allograft nephropathy.
    Falger JC; Mueller T; Arbeiter K; Boehm M; Regele H; Balzar E; Aufricht C
    Pediatr Transplant; 2006 Jun; 10(4):474-8. PubMed ID: 16712606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recovery of chronic renal impairment with sirolimus after lung transplantation.
    Venuta F; De Giacomo T; Rendina EA; Quattrucci S; Mercadante E; Cimino G; Ibrahim M; Diso D; Bachetoni A; Coloni GF
    Ann Thorac Surg; 2004 Dec; 78(6):1940-3. PubMed ID: 15561004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sirolimus in liver transplant recipients with renal dysfunction offers no advantage over low-dose calcineurin inhibitor regimens.
    DuBay D; Smith RJ; Qiu KG; Levy GA; Lilly L; Therapondos G
    Liver Transpl; 2008 May; 14(5):651-9. PubMed ID: 18433069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal function improves in liver transplant recipients when switched from a calcineurin inhibitor to sirolimus.
    Fairbanks KD; Eustace JA; Fine D; Thuluvath PJ
    Liver Transpl; 2003 Oct; 9(10):1079-85. PubMed ID: 14526403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.
    Bumbea V; Kamar N; Ribes D; Esposito L; Modesto A; Guitard J; Nasou G; Durand D; Rostaing L
    Nephrol Dial Transplant; 2005 Nov; 20(11):2517-23. PubMed ID: 15985508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of sirolimus vs. calcineurin inhibitor-based immunosuppressive therapies in liver transplantation.
    Zaghla H; Selby RR; Chan LS; Kahn JA; Donovan JA; Jabbour N; Genyk Y; Mateo R; Gagandeep S; Sher LS; Ramicone E; Fong TL
    Aliment Pharmacol Ther; 2006 Feb; 23(4):513-20. PubMed ID: 16441472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized controlled trial of late conversion from calcineurin inhibitor (CNI)-based to sirolimus-based immunosuppression in liver transplant recipients with impaired renal function.
    Watson CJ; Gimson AE; Alexander GJ; Allison ME; Gibbs P; Smith JC; Palmer CR; Bradley JA
    Liver Transpl; 2007 Dec; 13(12):1694-702. PubMed ID: 18044728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Everolimus with reduced calcineurin inhibitor in thoracic transplant recipients with renal dysfunction: a multicenter, randomized trial.
    Gullestad L; Iversen M; Mortensen SA; Eiskjaer H; Riise GC; Mared L; Bjørtuft O; Ekmehag B; Jansson K; Simonsen S; Gude E; Rundqvist B; Fagertun HE; Solbu D; Bergh CH
    Transplantation; 2010 Apr; 89(7):864-72. PubMed ID: 20061999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sirolimus as primary immunosuppressant for calcineurin inhibitor-related renal insufficiency after liver transplantation.
    Yang YJ; Li LX; He Q; Fan H; Jin ZK; Lang R; Kou JT; Li P; Xie DH; Chen DZ
    Hepatobiliary Pancreat Dis Int; 2007 Aug; 6(4):376-8. PubMed ID: 17690032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Everolimus in lung transplantation in Chile.
    Parada MT; Alba A; Sepúlveda C
    Transplant Proc; 2010; 42(1):328-30. PubMed ID: 20172343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Replacing calcineurin inhibitors with mTOR inhibitors in children.
    Sindhi R; Seward J; Mazariegos G; Soltys K; Seward L; Smith A; Kosmach B; Venkataramanan R
    Pediatr Transplant; 2005 Jun; 9(3):391-7. PubMed ID: 15910398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
    Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J
    Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement of renal function after the switch from a calcineurin inhibitor to everolimus in liver transplant recipients with chronic renal dysfunction.
    Castroagudín JF; Molina E; Romero R; Otero E; Tomé S; Varo E
    Liver Transpl; 2009 Dec; 15(12):1792-7. PubMed ID: 19938140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sirolimus addition is beneficial for renal allograft dysfunction due to simultaneous acute rejection episode and calcineurin inhibitor nephrotoxicity.
    Chang HR; Lee MH; Wen MC; Lian JD
    Transplant Proc; 2004 Nov; 36(9):2668-70. PubMed ID: 15621119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early sirolimus therapy in renal transplant recipients at high risk: is it justified?
    Halim MA; Al-Otaibi T; Johny KV; Hamid MH; Al-Waheeb S; Hasaneen H; Awadain WH; Nawas KM; El-Sayed A; Said T; Nair MP; Nampoory MR
    Transplant Proc; 2009 Sep; 41(7):2784-8. PubMed ID: 19765435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High rejection rate during calcineurin inhibitor-free and early steroid withdrawal immunosuppression in renal transplantation.
    Gelens MA; Christiaans MH; van Heurn EL; van den Berg-Loonen EP; Peutz-Kootstra CJ; van Hooff JP
    Transplantation; 2006 Nov; 82(9):1221-3. PubMed ID: 17102775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful conversion to rapamycin for calcineurin inhibitor-related neurotoxicity following liver transplantation.
    Forgacs B; Merhav HJ; Lappin J; Mieles L
    Transplant Proc; 2005 May; 37(4):1912-4. PubMed ID: 15919502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sirolimus ameliorated post lung transplant chylothorax in lymphangioleiomyomatosis.
    Ohara T; Oto T; Miyoshi K; Tao H; Yamane M; Toyooka S; Okazaki M; Date H; Sano Y
    Ann Thorac Surg; 2008 Dec; 86(6):e7-8. PubMed ID: 19021963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.